|
It was reported that the right atrial (ra) lead exhibited undersensing during atrial tachycardia/atrial fibrillation (at/af) stored episodes resulting in termination of at/af detected event(s) in progress and causing unnecessary atrial pacing.It was also reported that the left ventricular (lv) lead exhibited low impedance.Additionally, the cardiac resynchronization therapy defibrillator (crt-d) triggered a false observation for an increase in the lv lead threshold indicating that the increase was greater than the amplitude safety margin and may have compromised capture.The observation displayed question marks where a numerical value would typically be displayed.The ra lead, lv lead, and crt-d remain in use.No patient complications have been reported as a result of this event.
|
|
Continuation of d10: dtma1d4 crt-d, implanted: (b)(6) 2022, 6935m62 lead , implanted: (b)(6) 2022.5867-3m adaptor, implanted: (b)(6) 2022.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|